STAT NEWS
In Generic Drug Plants In China And India, Data Falsification Is Still A Problem.

READ

BLOOMBERG BUSINESSWEEK
Carcinogens Have Infiltrated the Generic Drug Supply in the U.S.

READ

THE NEW YORKER
The Birth-Tissue Profiteers

READ

REGULATORY FOCUS
Scope of FDA Draft Guidance on Nonbinding Feedback is Too Restrictive, Industry Argues

READ

MEDSCAPE
‘Scary World’ of Generic Drug Manufacturing, Revealed

READ

THE WALL STREET JOURNAL 
Open-Government Laws Fuel Hedge-Fund Profits
Hedge Funds Are Using FOIA Requests to Obtain Nonpublic Information From Federal Agencies

READ

BOTTLE OF LIES
The Inside Story of the Generic Drug Boom

READ

BLOOMBERG QUINT
Trouble Mounts For Biocon’s Bengaluru Plant

READ

Press Releases

Check our Press section for the latest press releases.

Get Complete Access to the Redica Systems Platform

Please submit your email address and one of our team members will contact you shortly to answer all of your questions and get you started with the new Enforcement Analytics platform.

Discover the power of the most comprehensive database of 483s in existence.

Our database of over 20,000 483s is retyped and tagged, making it easy to create an Observation Report in seconds.

Eliminate days of work and get your FREE personalized 483 Observation Report.